#USA #San Diego #medical technology #Channel Robotics #Endoscopic Robotics

Channel Robotics Secures $4.6 Million in Funding

Channel Robotics, a pioneering firm specializing in endoscopic robotics, has successfully completed a $2.5 million Seed+ funding round, which contributes to a total funding of $4.6 million. Led by True Ventures, a notable early-stage venture capital firm, this financing is pivotal for the continued development of the company’s revolutionary handheld endoscopic robotic platform.

Advancing Innovation in Healthcare

Founded in San Diego by Dr. Philip Weissbrod, a physician-scientist, and Dr. Michael Yip, a roboticist, Channel Robotics is on a mission to democratize access to advanced endoscopic procedures. The company's innovative platform enhances dexterity using existing flexible endoscopes. Unlike traditional robotic systems, which are often cumbersome and costly, this handheld device aims to make advanced medical interventions more accessible across various healthcare settings, including hospitals and outpatient surgical centers.

Dr. Weissbrod emphasizes the aim to integrate sophisticated robotic capabilities in a practical, scalable, and economical manner. The funding from True Ventures not only supports technological advancement but also strategic growth within the healthcare sector.

Funding Background and Strategic Support

Just prior to this Seed+ round, Channel Robotics raised $2.1 million through its Seed round with support from Defined Ventures and Old Line Capital Partners. This collaborative backing provides not only financial resources but also invaluable expertise in medical technology and business strategy.

Rohit Sharma, a partner at True Ventures, commended the founders for their combination of clinical experience and robotic knowledge, highlighting their commitment to addressing significant challenges within healthcare. This belief is also echoed by Dr. Weissbrod, who noted the importance of the funding in bolstering their development efforts and bringing accessible solutions to more patients.

Key Milestones Ahead

The $4.6 million in total funding will support crucial initiatives, including:

• - Continued refinement and validation of the prototype
• - Expansion of engineering and product development
• - Preparation for FDA submission set for 2027
• - Enhancement of manufacturing and quality assurance systems
• - Planning for commercial launch after achieving regulatory clearance

With these measures in place, Channel Robotics aims to position itself as a leader in the evolving landscape of endoscopic robotics.

The Future of Endoscopic Procedures

As the healthcare industry adapts to advancements in technology, Channel Robotics is determined to provide solutions that simplify the adoption of robotic systems in clinical environments. The company aspires to shape the future of endoscopic robotics through innovations that resonate with practitioners and patients alike.

In conclusion, Channel Robotics' recent funding achievement sets a promising trajectory for developing an endoscopic platform that combines user-friendly design with advanced technology, ultimately transforming patient care options across various medical facilities. As we anticipate further developments, the collaboration between technical expertise and medical innovation at Channel Robotics could redefine minim-invasive surgeries.